The etiology of MPNs remains somewhat unknown, but acquired somatic MPN driver mutations in JAK2, MPL or CALR that alter the JAK-STAT signaling pathway are found in most patients [16]. Here, JAK2 is linked to myeloproliferative neoplasm.